Brief: Astrazeneca Pharma India Terminates Distribution Agreement For Dapagliflozin With Abbott Healthcare
28/05/2021 09:39
May 28 (Reuters) - Astrazeneca Pharma India ASTR.NS :
* TERMINATION OF DISTRIBUTION AGREEMENT FOR DAPAGLIFLOZIN
BETWEEN
CO, ABBOTT HEALTHCARE
Source text for Eikon: ID:nBSE1gjy9B
Further company coverage: ASTR.NS ABOT.NS ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbott India
See all newsJP Morgan downgrades Abbott India to 'neutral' citing growth headwinds
Brief: Abbott India Partners With Novo Nordisk India To Launch Extensior
Brief: Abbott India Dec-Quarter Profit 3.76 Billion Rupees
Brief: Abbott India Receives Tax Penalty Of 24 Million Rupees
Brief: Central Government Approves Kartik Rajendran As MD of Abbott India